SRAJ Stock Overview
PT Sejahteraraya Anugrahjaya Tbk provides medical services in Indonesia.
Sejahteraraya Anugrahjaya Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||Rp181.00|
|52 Week High||Rp575.00|
|52 Week Low||Rp151.00|
|1 Month Change||-9.50%|
|3 Month Change||-34.89%|
|1 Year Change||19.87%|
|3 Year Change||-19.20%|
|5 Year Change||-12.98%|
|Change since IPO||-9.50%|
Recent News & Updates
|SRAJ||ID Healthcare||ID Market|
Return vs Industry: SRAJ exceeded the ID Healthcare industry which returned 14.4% over the past year.
Return vs Market: SRAJ exceeded the ID Market which returned 15.6% over the past year.
|SRAJ Average Weekly Movement||6.1%|
|Healthcare Industry Average Movement||5.2%|
|Market Average Movement||6.3%|
|10% most volatile stocks in ID Market||12.0%|
|10% least volatile stocks in ID Market||3.0%|
Stable Share Price: SRAJ is not significantly more volatile than the rest of ID stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: SRAJ's weekly volatility has decreased from 13% to 6% over the past year.
About the Company
PT Sejahteraraya Anugrahjaya Tbk provides medical services in Indonesia. It operates through two segments, Inpatient Including Its Supporting Facilities; and Outpatient Including Its Supporting Facilities. The company operates and manages hospitals under the Mayapada Hospital name.
Sejahteraraya Anugrahjaya Fundamentals Summary
|SRAJ fundamental statistics|
Is SRAJ overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SRAJ income statement (TTM)|
|Cost of Revenue||Rp1.25t|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||13.77|
|Net Profit Margin||8.59%|
How did SRAJ perform over the long term?See historical performance and comparison
Is Sejahteraraya Anugrahjaya undervalued compared to its fair value and its price relative to the market?
Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate SRAJ's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate SRAJ's fair value for valuation analysis.
Price To Earnings Ratio
PE vs Industry: SRAJ is good value based on its PE Ratio (13.1x) compared to the ID Healthcare industry average (20.2x).
PE vs Market: SRAJ is good value based on its PE Ratio (13.1x) compared to the ID market (18.8x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SRAJ's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: SRAJ is good value based on its PB Ratio (1.1x) compared to the ID Healthcare industry average (1.9x).
How is Sejahteraraya Anugrahjaya forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sejahteraraya Anugrahjaya has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Sejahteraraya Anugrahjaya performed over the past 5 years?
Past Performance Score3/6
Past Performance Score 3/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SRAJ has high quality earnings.
Growing Profit Margin: SRAJ became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: SRAJ has become profitable over the past 5 years, growing earnings by 47% per year.
Accelerating Growth: SRAJ has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: SRAJ has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (121.6%).
Return on Equity
High ROE: SRAJ's Return on Equity (8.6%) is considered low.
How is Sejahteraraya Anugrahjaya's financial position?
Financial Health Score1/6
Financial Health Score 1/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: SRAJ's short term assets (IDR1,021.5B) do not cover its short term liabilities (IDR2,659.2B).
Long Term Liabilities: SRAJ's short term assets (IDR1,021.5B) exceed its long term liabilities (IDR285.2B).
Debt to Equity History and Analysis
Debt Level: SRAJ's net debt to equity ratio (86.1%) is considered high.
Reducing Debt: SRAJ's debt to equity ratio has increased from 25.5% to 122.5% over the past 5 years.
Debt Coverage: SRAJ's debt is not well covered by operating cash flow (14.3%).
Interest Coverage: SRAJ's interest payments on its debt are not well covered by EBIT (2.6x coverage).
What is Sejahteraraya Anugrahjaya current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SRAJ's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SRAJ's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SRAJ's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SRAJ's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SRAJ has not reported any payouts.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Grace Riady (45 yo)
Ms. Grace Dewi Riady has been President Commissioner of PT Maha Properti Indonesia Tbk (formerly known as PT Propertindo Mulia Investama Tbk) since May 18, 2018. Ms. Riady has been the President Director o...
Experienced Management: SRAJ's management team is seasoned and experienced (10 years average tenure).
Experienced Board: SRAJ's board of directors are seasoned and experienced ( 10 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
PT Sejahteraraya Anugrahjaya Tbk's employee growth, exchange listings and data sources
- Name: PT Sejahteraraya Anugrahjaya Tbk
- Ticker: SRAJ
- Exchange: IDX
- Founded: 1991
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: Rp2.172t
- Shares outstanding: 12.00b
- Website: https://www.mayapadahospital.com
Number of Employees
- PT Sejahteraraya Anugrahjaya Tbk
- Jalan Honoris Raya Kav. 6
- Kota Modern (Modernland)
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/18 00:00|
|End of Day Share Price||2022/05/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.